The enduring mission of Science News, established in the nascent years of the 20th century, continues to serve as a…
Read More

The enduring mission of Science News, established in the nascent years of the 20th century, continues to serve as a…
Read More
In 2024, OpenAI CEO Sam Altman famously predicted that a single entrepreneur, leveraging the transformative power of artificial intelligence, could…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have identified multiple classes…
Read More
A telehealth startup, MEDVi, recently lauded by The New York Times as a prime example of an AI-driven billion-dollar enterprise,…
Read More
Recent scientific investigations have unveiled a concerning correlation between the pervasive presence of microplastics in the environment and the rising…
Read More
In an era increasingly shaped by the transformative power of artificial intelligence, a Los Angeles-based telehealth startup, MEDVi, has captured…
Read More
A groundbreaking device, dubbed a "living pharmacy," capable of producing multiple therapeutic agents simultaneously within the body, has demonstrated significant…
Read More
The pervasive presence of microplastics in the global environment has long been a concern for marine biologists and ecologists, but…
Read More
Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More